Le colloque est reconnu SHV/FSSF/FSL
Les points de crédits sont en demande à: SSGO - SSMO - SRO - SSP - SSR

Flyer de la conférence publique : "Psycho-oncologie et prise en charge du cancer du sein", Auditoire César Roux, jeudi 6 octobre 2022 de 18h à 20h30.

Chères collègues, chers confrères,

Le groupe genevois de formation continue en sénologie a le plaisir de vous convier à un symposium le vendredi 7 octobre 2022. Cette demi-journée est dédiée à l'intelligence artificielle pour rester adéquat dans nos démarches en pleine évolution.

Notre groupe s'est constitué il y a plus de 2 ans, il réunit les acteurs de la médecine publique et de la médecine privée qui ont souhaité unir leurs compétences pour assurer une formation continue de haut niveau dans le domaine de la sénologie dans le canton de Genève. Les centres du sein genevois accrédités et les membres du SONGe (Réseau de Sénologie et onco-gynécologie genevois) organisent trois formations et un symposium par an.

Nous vous invitons à ce 2e symposium en ce début du mois d'octobre et nous réjouissons des échanges constructifs et dynamiques que nous pourrons conduire.

Groupe genevois de formation continue en sénologie

1st INTERNATIONAL WORKSHOP ON PATIENT AND PUBLIC INVOLVEMENT IN CANCER RESEARCH

Dear Colleagues, Dear Partners,

Patient and Public Involvement (PPI) is changing the way we think about research in healthcare. The notion of research performed 'with' or 'by' members of the public rather than 'to', 'about' or 'for' them (as defined by NIHR-INVOLVE) requires us to rethink traditional research approaches and design new strategies.

With PPI becoming a hallmark of research culture in many countries, Switzerland has seen the emergence of several exciting initiatives in recent years. In Western Switzerland, the " Laboratoire des Patients " (Patient Lab) was founded to specifically support PPI in cancer research. A joint platform between the Geneva and Lausanne University Hospitals (HUG & CHUV), as well as the Universities of Geneva and Lausanne, the Patient Lab is affiliated with the Swiss Cancer Center Léman (SCCL).

We are thus very happy to invite you to the First International Workshop on PPI in Cancer Research, which will mark the official presentation of the SCCL Patient Lab to the wider research and patient community. On this occasion, we are excited to welcome a panel of internationally renowned experts in the field. Researchers and patient partners will speak alongside to give their insights into recent developments and their experiences applying PPI in cancer research. Breakout discussions and posters featuring selected abstracts will allow us to further plunge into different themes and together explore emerging strategies.

We are looking forward to an excellent meeting and hope to see you all in Lausanne on Nov 01, 2022!

The Organizing Committee
Alfredo Addeo, Christine Aeschlimann, Sara Colomer-Lahiguera, Tourane Corbière, Manuela Eicher, Susan Gasser, Marie-Pascale Pomey

Please note : The main event language is English. Simultaneous interpretation of keynote lectures into French and German will be available. Breakout sessions will be held multi-lingual.

 

REGISTRATIONS ARE OPEN UNTIL OCTOBER 23, 2022.

ABSTRACT SUBMISSIONS WERE OPEN UNTIL SEPTEMBER 20, 2022. THE DEADLINE HAS NOW EXPIRED.

Abstract rules

Dear Swiss reproductive physicians, dear Swiss embryologists,

Last year we launched our 1st Post-ESHRAM in Switzerland. 6 Swiss speakers presented the highlights of ESHRE and ASRM 2021. As you remember or might have heard about, the meeting was a great success. We not only learned a lot, we also had a good time during the meeting and at the Swiss evening in "Kornhauskeller" in Bern.

Therefore, Post-ESHRAM will take place again in 2022. The same speakers are going to present the scientific and clinical highlights of ESHRE and ASRM 2022. The presentations will again be discussed intensively by the audience to deepen our knowledge of both, reproductive medicine and embryology. The meeting is designed to address all qualified physicians and embryologists as well as those still in training.

We are also looking forward to our Swiss evening which will take place in a very nice and rather quite Italian restaurant.

The SGRM board is looking forward to seeing you at our 2nd Post-ESHRAM in Bern,

Michael von Wolff

Room reservations can be sent by mail directly to reception(at)hotelbern.ch until 30 September.
Please indicate the keyword for the reservation with ESHRAM 2022.
The room rate is CHF 185.00 including breakfast, the guest tax is CHF 5.30 per person.

Venue: University Hospital Zürich - Grosser Hörsaal, NORD1 D Room 304 large lecture hall

09.30 - 10.15 Welcome coffee

10.15 - 10.20 Welcome, Introduction (JC Tille, Geneva)

10.20 - 11.50 Slide Seminar Part I
Cases 1-2: Dr Wiebke Solass, Bern
Cases 3-4: Dr Delfyne Hastir, Lausanne
Cases 5-6: Dr Essia Saiji, Geneva

11.50 - 12.30 Snack break

12.30 - 14.00 General Assembly SGPath-SSPath

14.00 - 14.15 Coffee break

14.15 - 15.15 Slide Seminar Part II
Cases 7-8: Dr Tatjana Vlajnic, Basel Cases
9-10: Prof. Luca Mazzuchelli, Locarno

15.15 Closing words - End of Seminar (JC Tille)

--------------------

The Slide seminar and General assembly are held in face-to-face and will not be broadcasted.

--------------------

Deadline for submission of diagnoses:   Wednesday, November 9, 17.00

The platform will be open as of October 31 on https://sgpathslideseminar.ch/

--------------------

Credits given by the SGPath:
Participation at the slide seminar: 3 credit points
Submission of diagnosis: 2 credit points

Chers-ères Collègues,

Nous avons l'immense plaisir de vous convier à la Troisième rencontre Franco-Suisse de gynécologie oncologique.

Depuis quelques années nous observons chaque année des avancées qui révolutionnent non seulement la prise en charge des tumeurs gynécologiques fréquentes (utérus et ovaire), mais également des tumeurs plus rares, et notamment les cancers du col utérin et de la vulve.

Cette évolution est source d’espoir mais également de controverse, avec des implications pour l’ensemble des professionnels engagés dans le traitement des tumeurs gynécologiques.

Dans un esprit convivial de partage de connaissances, moyennant un programme scientifique francophone étoffé et animé par des spécialistes éminents de la Suisse et de la France, nous vous invitons à aborder les avancées dans le domaine du cancer du col et de la vulve, tout en discutant également des dernières avancées thérapeutiques du cancer de l’utérus et de l’ovaire.

Cet événement s'adresse aux gynécologues, oncologues, radio-oncologues, chirurgiens viscéraux, psychologues, psychiatres, médecins généralistes, soignants, sages-femmes, physiothérapeutes et tout autre spécialiste intéressé par la problématique des tumeurs gynécologiques.

Nous espérons vous y accueillir nombreux-ses,

Au nom du comité d'organisation
Pr P. Mathevet, Dre F. Herrera, Dr A. Sarivalasis

Crédits:
SSGO : 10 points de crédit spécifiques
SSMO : 10 points de crédit spécifiques
SSRO : 10 points de crédit spécifiques
SSPath: en demande
ASI : label en demande

Ce cours s'adresse aux radiologues, urologues, oncologues, médecins nucléaristes et techniciens en radiologie médicale impliqués dans la prise en charge des cancers de la prostate et de la vessie.

Au terme de cette demi-journée de cours, les participants auront revu les principes du diagnostic et du suivi radiologique des cancers de prostate et de vessie. De plus, ils seront sensibilisés aux dernières mises à jour et recommandations d'imagerie dans ce domaine tel que la place de l'IRM prostatique dans la prise en charge thérapeutique ou la valeur ajoutée de l'IRM de vessie. De plus, nous discuterons des comptes rendus structuré comme le PI-RDS et le VI-RADS. Nous aborderons également ces cancers d'un point de vue multidisciplinaire en confrontant les différents points de vue des urologues, oncologues, médecins nucléaristes et radiologues interventionnels. Les principaux pièges diagnostiques seront abordés au travers de cas cliniques illustratifs.

Dear colleagues

With great pleasure we would like to invite you all to the 54^th Annual Congress of the Swiss Society of Nephrology at the well-known venue in Interlaken. We all do not know how the Coronavirus pandemic will evolve, but we really hope that we will be able to meet you all in person this year. Individual and personal exchange has been lacking the last two years, and by this experience we have learnt how important and valuable it really is.

We have been working with a small group of colleagues including Sophie de Seigneux and Seraina von Moos to organize a congress fostering interactions and innovation. We are proud to announce a number of excellent keynote speakers: Prof. David Cooper will join us from Boston and give an update on the recent advances in xenotransplantation – he being one of the icons in this field for several decades. Prof. Claudio Ronco will give his new insights in renal replacement therapies in his talk "The promise of absorption – going from wearable devices to water-free dialysis". Prof. Pierre Delanaye from Belgium will introduce us to his research on assessment of renal function and renal aging. Last, but not least, Prof. Lauren Clark will join us from the new Institute of implementation science at Zurich University and tell us, how we can do better in translating our research achievements in real advances for our patients.

We will introduce a number of novel presentation formats for abstracts and case reports – moving away from traditional poster walks. Join us for the innovative pecha-kucha sessions and elevator pitches and help to choose the prize winners together with us! Also, the Young Swiss nephrologist's picture challenge will again be part of the program, and our young colleagues will also present a special attraction during the Apero on Thursday evening.

So, many surprises are awaiting you. Just join in and enjoy this year's SGN/SSN meeting!

Kind regards

Thomas Fehr & Pietro Cippà
Co-presidents of the congress